Robert Redfield

14.8k total citations · 1 hit paper
160 papers, 5.4k citations indexed

About

Robert Redfield is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Robert Redfield has authored 160 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Infectious Diseases, 81 papers in Virology and 30 papers in Immunology. Recurrent topics in Robert Redfield's work include HIV Research and Treatment (81 papers), HIV/AIDS drug development and treatment (60 papers) and HIV/AIDS Research and Interventions (39 papers). Robert Redfield is often cited by papers focused on HIV Research and Treatment (81 papers), HIV/AIDS drug development and treatment (60 papers) and HIV/AIDS Research and Interventions (39 papers). Robert Redfield collaborates with scholars based in United States, Nigeria and Canada. Robert Redfield's co-authors include Anthony S. Fauci, Brett P. Giroir, Donald S. Burke, Alonso Heredia, Charles E. Davis, N L Michael, Nhut Le, Maryanne Vahey, Gideon Sjoberg and Mohammad M. Sajadi and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Robert Redfield

153 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ending the HIV Epidemic

2019 1.0k citations Robert Redfield et al. profile →

Peers

Countries citing papers authored by Robert Redfield

Since Specialization

Citations

This map shows the geographic impact of Robert Redfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Redfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Redfield more than expected).

Fields of papers citing papers by Robert Redfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Redfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Redfield. The network helps show where Robert Redfield may publish in the future.

Co-authorship network of co-authors of Robert Redfield

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Redfield. A scholar is included among the top collaborators of Robert Redfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Redfield. Robert Redfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVID 2025 ·Viruses ·Swayam Prakash, (unknown), (unknown), Delia F. Tifrea, Cesar Figueroa, (unknown), James F. Young, Greg Glenn, (unknown), Trevor Jones, Robert Redfield, Lbachir BenMohamed	0
2	Health Care Autonomy of Women Living with HIV 2019 ·New England Journal of Medicine ·Robert Redfield, Surbhi Modi, Cynthia A. Moore, Augustina Delaney, Margaret A. Honein, (unknown)	3
3	Suppression of Active HIV-1 Infection in CD34 ⁺ Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs 2019 ·AIDS Research and Human Retroviruses ·Olga Latinovic, (unknown), Yutaka Tagaya, Alonso Heredia, Sandra Medina-Moreno, Juan Carlos Zapata, Marvin S. Reitz, Joseph Bryant, Robert Redfield	8
4	High Prevalence of Abacavir-associated L74V/I Mutations in Kenyan Children Failing Antiretroviral Therapy 2017 ·The Pediatric Infectious Disease Journal ·Eric J. Dziuban, (unknown), (unknown), Evelyn Ngugi, Guoqing Zhang, (unknown), (unknown), Karidia Diallo, Lucy Nganga, Abraham Katana, Chunfu Yang, Emilia Rivadeneira, Irene Mukui, (unknown), Robert Redfield, Elliot Raizes	4
5	Virologic and Immunologic Outcomes in HIV-Infected Patients with Cancer 2016 ·AIDS Research and Human Retroviruses ·David J. Riedel, Kristen A. Stafford, (unknown), Robert Redfield	3
6	Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice 2015 ·Proceedings of the National Academy of Sciences ·Alonso Heredia, Nhut Le, Ronald B. Gartenhaus, Edward A. Sausville, Sandra Medina-Moreno, Juan Carlos Zapata, Charles E. Davis, Robert C. Gallo, Robert Redfield	79
7	Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo Studies 2015 ·AIDS Research and Human Retroviruses ·Olga Latinovic, Sandra Medina-Moreno, (unknown), Neelakshi Gohain, Juan Carlos Zapata, Marzena Pazgier, Marvin S. Reitz, Joseph Bryant, Robert Redfield	3
8	HIV-associated lymphoma sub-type distribution, immunophenotypes and survival in an urban clinic population 2015 ·Leukemia & lymphoma ·David J. Riedel, Anne F. Rositch, Robert Redfield, William A. Blattner	18
9	Influence of Transportation Cost on Long-Term Retention in Clinic for HIV Patients in Rural Haiti 2014 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), (unknown), Ulrike K. Buchwald, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Robert Redfield, Anthony Amoroso	13
10	Elevated hypermutation levels in HIV-1 natural viral suppressors 2013 ·Virology ·Lindsay M. Eyzaguirre, Manhattan Charurat, Robert Redfield, William A. Blattner, Jean K. Carr, Mohammad M. Sajadi	25
11	Signature Biochemical Properties of Broadly Cross-Reactive HIV-1 Neutralizing Antibodies in Human Plasma 2012 ·Journal of Virology ·Mohammad M. Sajadi, George K. Lewis, Michael S. Seaman, Yongjun Guan, Robert Redfield, Anthony L. DeVico	11
12	Safety, Tolerability, and Efficacy of KP-1461 as Monotherapy for 124 Days in Antiretroviral-Experienced, HIV Type 1-Infected Subjects 2012 ·AIDS Research and Human Retroviruses ·Charles B. Hicks, Patrick G. Clay, Robert Redfield, Jay Lalezari, (unknown), Stefan Schneider, Michael Sension, MaryPeace McRae, Jean‐Pierre Laurent	13
13	Modulation of K65R Selection by Zidovudine Inclusion: Analysis of HIV Resistance Selection in Subjects with Virologic Failure Receiving Once-Daily Abacavir/Lamivudine/Zidovudine and Tenofovir DF (Study COL40263) 2009 ·AIDS Research and Human Retroviruses ·Lisa Ross, Richard Elion, Randall Lanier, Edwin DeJesus, Calvin Cohen, Robert Redfield, Joseph Gathe, (unknown), Linda Yau, (unknown), Belinda Ha	9
14	Tenofovir and Abacavir Combination Therapy: Lessons Learned from an Urban Clinic Population 2007 ·AIDS Patient Care and STDs ·Bruce L. Gilliam, Mohammad M. Sajadi, Anthony Amoroso, Charles E. Davis, Farley Cleghorn, Robert Redfield	9
15	Successful Treatment with Atazanavir and Lopinavir/Ritonavir Combination Therapy in Protease Inhibitor-Susceptible and Protease Inhibitor-Resistant HIV-Infected Patients 2006 ·AIDS Patient Care and STDs ·Bruce L. Gilliam, Kirk M. Chan‐Tack, Roula Qaqish, Richard A. Rode, Lori E. Fantry, Robert Redfield	9
16	Modification and structure–activity relationship of a small molecule HIV-1 inhibitor targeting the viral envelope glycoprotein gp120 2005 ·Organic & Biomolecular Chemistry ·Jingsong Wang, Nhut Le, Alonso Heredia, Haijing Song, Robert Redfield, Lai‐Xi Wang	24
17	Resveratrol glucuronides as the metabolites of resveratrol in humans: Characterization, synthesis, and anti-HIV activity 2004 ·Journal of Pharmaceutical Sciences ·Lai‐Xi Wang, Alonso Heredia, Haijing Song, Zhaojun Zhang, Biao Yu, Charles E. Davis, Robert Redfield	106
18	Synergistic Inhibition of HIV-1 in Activated and Resting Peripheral Blood Mononuclear Cells, Monocyte-Derived Macrophages, and Selected Drug-Resistant Isolates With Nucleoside Analogues Combined With a Natural Product, Resveratrol 2000 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Alonso Heredia, Charles E. Davis, Robert Redfield	67
19	HIV Infection: The Clinical Picture 1988 ·Scientific American ·Robert Redfield, Donald S. Burke	121
20	The social uses of social science 1963 ·University of Chicago Press eBooks ·(unknown), Robert Redfield	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact